OMC
OUP Management Company Portfolio holdings
AUM
$44.5M
This Quarter Return
+37.99%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$58.6M
AUM Growth
+$58.6M
(+17%)
Cap. Flow
-$3.89M
Cap. Flow
% of AUM
-6.63%
Top 10 Holdings %
Top 10 Hldgs %
99.29%
Holding
14
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
IonQ
IONQ
|
$2.4M |
| 2 |
Prime Medicine
PRME
|
$1.49M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $18.2M | 31.01% |
2,937,615
| – | – |
|
|
DICE
2
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $12.5M | 21.26% |
268,346
| – | – |
|
|
JBIO
3
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $10.4M | 17.66% |
603,762
| – | – |
|
|
CYT
4
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $6.39M | 10.91% |
2,459,572
| – | – |
|
5
PMV Pharmaceuticals
PMVP
$74.2M
| $6.19M | 10.56% |
989,232
| – | – |
|
6
Vor Biopharma
VOR
$250M
| $1.16M | 1.97% |
374,714
| – | – |
|
|
LENZ
7
LENZ Therapeutics
LENZ
$1.1B
| $1.06M | 1.8% |
406,308
| – | – |
|
8
Cartesian Therapeutics
RNAC
$261M
| $966K | 1.65% |
862,543
| – | – |
|
|
EFTR
9
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $852K | 1.45% |
1,025,697
| – | – |
|
10
Precision BioSciences
DTIL
$57.8M
| $591K | 1.01% |
1,123,913
| – | – |
|
11
Spero Therapeutics
SPRO
$116M
| $361K | 0.62% |
249,070
| – | – |
|
12
Q32 Bio
QTTB
$20.9M
| $56.6K | 0.1% |
64,000
| – | – |
|
|
13
IonQ
IONQ
$12.7B
| – | – |
-389,668
| Closed | -$2.4M |
|
|
14
Prime Medicine
PRME
$578M
| – | – |
-121,255
| Closed | -$1.49M |
|